SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 16 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,770 | -5.7% | 281,107 | 0.0% | 0.00% | – |
| Q4 2022 | $16,726 | -7.1% | 281,107 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | -57.1% | 281,107 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -67.4% | 281,107 | 0.0% | 0.00% | – |
| Q1 2022 | $129,000 | -74.4% | 281,107 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $503,000 | – | 281,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 108,485 | $8,136 | 0.00% |
| Shaolin Capital Management LLC | 465,717 | $33 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,765 | $893 | 0.00% |
| MORGAN STANLEY | 148,939 | $10,426 | 0.00% |
| Walleye Trading LLC | 15,505 | $1,085 | 0.00% |
| Walleye Capital LLC | 23,258 | $1,628 | 0.00% |
| Tower Research Capital LLC (TRC) | 48 | $4 | 0.00% |
| LMR Partners LLP | 539,588 | $37,771 | 0.00% |
| NewEdge Advisors, LLC | 1,072 | $75 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |